frest 1 mg/g gél
as grindeks, lotyšsko - dimetindén - 46 - dermatologica
ipigrix 20 mg tablety
as grindeks, lotyšsko - inhibítory cholínesterázy - 67 - parasympathomimetica
ipigrix 15 mg/ml injekčný roztok
as grindeks, lotyšsko - inhibítory cholínesterázy - 67 - parasympathomimetica
ipigrix 5 mg/ml injekčný roztok
as grindeks, lotyšsko - inhibítory cholínesterázy - 67 - parasympathomimetica
salvudex 5 mg/ml injekčný roztok
as grindeks, lotyšsko - bupivakaín - 01 - anaesthetica (lokÁlne)
loperamid grindeks 2 mg tvrdé kapsuly
as grindeks, lotyšsko - loperamid - 49 - digestiva, adsorbentia, acida
nostiriazyn 100 mg tvrdé kapsuly s riadeným uvoľňovaním
as olainfarm, lotyšsko - nitrofurantoín - 42 - chemotherapeutica (vratane tuberkulostatik)
cancidas (previously caspofungin msd)
merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimykotika na systémové použitie - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.
clopidogrel teva generics b.v.
teva pharma b.v. - clopidogrel (as hydrochloride) - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotické činidlá - klopidogrel je indikovaný u dospelých na prevenciu atherothrombotic udalosti v:pacienti, ktorí trpia infarktu myokardu (od niekoľkých dní až menej ako 35 dní), ischaemic zdvih (od 7 dní do menej ako 6 mesiacov) alebo zriadené periférneho arteriálneho ochorenia. patients suffering from acute coronary syndrome:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st segment elevation akútnom infarkte myokardu v kombinácii s asa u medicínsky liečiť pacientov nárok na thrombolytic therapy. Ďalšie informácie nájdete v časti 5.